Related references
Note: Only part of the references are listed.Pain Freedom at 2 Hours in Migraine after Telcagepant 300 mg
Peer Tfelt-Hansen
CNS DRUGS (2011)
Total Migraine Freedom, a Potential Primary Endpoint to Assess Acute Treatment in Migraine: Comparison to the Current FDA Requirement Using the Complete Rizatriptan Study Database
Anthony J. Rodgers et al.
HEADACHE (2011)
Overview of diagnosis and management of paediatric headache. Part II: therapeutic management
Cristiano Termine et al.
JOURNAL OF HEADACHE AND PAIN (2011)
A double-blind, randomized, multicenter, Italian study of frovatriptan versus rizatriptan for the acute treatment of migraine
Lidia Savi et al.
JOURNAL OF HEADACHE AND PAIN (2011)
Randomized double-blind comparison of tolfenamic acid and paracetamol in migraine
B. H. Larsen et al.
ACTA NEUROLOGICA SCANDINAVICA (2010)
PROPRANOLOL USED IN PROPHYLAXIS OF MIGRAINE IN CHILDREN
Johnny Ludvigsson
ACTA NEUROLOGICA SCANDINAVICA (2010)
CONSORT 2010 Statement: Updated Guidelines for Reporting Parallel Group Randomized Trials
Kenneth F. Schulz et al.
ANNALS OF INTERNAL MEDICINE (2010)
Guidelines for controlled trials of drugs in tension-type headache: Second edition
L. Bendtsen et al.
CEPHALALGIA (2010)
Design considerations in migraine with aura trials: Learning from experience
Elizabeth Loder
CEPHALALGIA (2010)
Acute treatment of migraine with the selective 5-HTIF receptor agonist lasmiditan - A randomised proof-of-concept trial
Michel D. Ferrari et al.
CEPHALALGIA (2010)
Randomized, controlled trial of telcagepant over four migraine attacks
Andrew P. Ho et al.
CEPHALALGIA (2010)
On the methodology of drug trials in migraine with aura
Anne Werner Hauge et al.
CEPHALALGIA (2010)
Prevention of episodic migraine with topiramate: a prospective 24-week, open-label, flexible-dose clinical trial with optional 24 weeks follow-up in a community setting
R. Malessa et al.
CURRENT MEDICAL RESEARCH AND OPINION (2010)
Triptans for the Management of Migraine
Mollie M. Johnston et al.
DRUGS (2010)
Prevention and Treatment of Menstrual Migraine
E. Anne MacGregor
DRUGS (2010)
Early Responses in Randomized Clinical Trials of Triptans in Acute Migraine Treatment. Are They Clinically Relevant? A Comment
Peer Tfelt-Hansen
HEADACHE (2010)
A Prospective Comparison Between ICHD-II and Probability Menstrual Migraine Diagnostic Criteria
Dawn A. Marcus et al.
HEADACHE (2010)
Health-Related Quality of Life, Disability and Severity of Disease in Patients With Migraine Attending to a Specialty Headache Center
Matilde Leonardi et al.
HEADACHE (2010)
Research Validation of the World Health Organization Disability Assessment Schedule, WHODAS-2 in patients with chronic diseases
Olatz Garin et al.
HEALTH AND QUALITY OF LIFE OUTCOMES (2010)
CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials
David Moher et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2010)
Are the current IHS guidelines for migraine drug trials being followed?
Anders Hougaard et al.
JOURNAL OF HEADACHE AND PAIN (2010)
Frovatriptan versus zolmitriptan for the acute treatment of migraine: a double-blind, randomized, multicenter, Italian study
Vincenzo Tullo et al.
NEUROLOGICAL SCIENCES (2010)
Disability and functional profiles of patients with migraine measured with ICF classification
Alberto Raggi et al.
INTERNATIONAL JOURNAL OF REHABILITATION RESEARCH (2010)
Modified intention to treat reporting in randomised controlled trials: systematic review
Iosief Abraha et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
MENU LABELING: KNOWLEDGE FOR A HEALTHIER AMERICA
Tamara Schulman
HARVARD JOURNAL ON LEGISLATION (2010)
Minimal important differences in the Migraine-Specific Quality of Life Questionnaire (MSQ) version 2.1
J. C. Cole et al.
CEPHALALGIA (2009)
Short-term frovatriptan for the prevention of difficult-to-treat menstrual migraine attacks
J. L. Brandes et al.
CEPHALALGIA (2009)
Investigation of the role of mGluR5 inhibition in migraine: a proof of concept study of ADX10059 in acute treatment of migraine
P. J. Goadsby et al.
CEPHALALGIA (2009)
Topiramate Versus Amitriptyline in Migraine Prevention: A 26-Week, Multicenter, Randomized, Double-Blind, Double-Dummy, Parallel-Group Noninferiority Trial in Adult Migraineurs
David W. Dodick et al.
CLINICAL THERAPEUTICS (2009)
EFNS guideline on the drug treatment of migraine - revised report of an EFNS task force
S. Evers et al.
EUROPEAN JOURNAL OF NEUROLOGY (2009)
Rizatriptan 10-mg ODT for Early Treatment of Migraine and Impact of Migraine Education on Treatment Response
Roger K. Cady et al.
HEADACHE (2009)
Topiramate for Migraine Prevention in a Naturalistic Setting: Results From an Open Label, Flexible Dose Study
Gereon Nelles et al.
HEADACHE (2009)
Safety and Tolerability of Short-Term Preventive Frovatriptan: A Combined Analysis
E. Anne MacGregor et al.
HEADACHE (2009)
Effects of tonabersat on migraine with aura: a randomised, double-blind, placebo-controlled crossover study
Anne W. Hauge et al.
LANCET NEUROLOGY (2009)
Randomized, controlled trial of telcagepant for the acute treatment of migraine
K. M. Connor et al.
NEUROLOGY (2009)
Design, analysis, and presentation of crossover trials
Edward J. Mills et al.
TRIALS (2009)
Anticonvulsants in migraine prophylaxis: a Cochrane review
W. M. Mulleners et al.
CEPHALALGIA (2008)
Early vs. non-early intervention in acute migraine - 'Act when Mild (AwM)'. A double-blind, placebo-controlled trial of almotriptan
P. J. Goadsby et al.
CEPHALALGIA (2008)
Evaluation and registration of adverse events in clinical drug trials in migraine
P. Tfelt-Hansen et al.
CEPHALALGIA (2008)
Guidelines for controlled trials of prophylactic treatment of chronic migraine in adults
S. Silberstein et al.
CEPHALALGIA (2008)
Favorable response to analgesics does not predict a benign etiology of headache
Jennifer V. Pope et al.
HEADACHE (2008)
Effect of early intervention with almotriptan vs placebo on migraine-associated functional disability: Results from the AEGIS trial
Frederick Freitag et al.
HEADACHE (2008)
Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues
Roger Cady et al.
HEADACHE (2008)
Headache Impact Test-6 (HIT-6) Scores for Migraine Patients: Their Relation to Disability as Measured from a Headache Diary
Hae Eun Shin et al.
JOURNAL OF CLINICAL NEUROLOGY (2008)
Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial
Tony W. Ho et al.
LANCET (2008)
Randomized controlled trial of an oral CGRP receptor antagonist, MK-0974, in acute treatment of migraine
T. W. Ho et al.
NEUROLOGY (2008)
Patients' preferences within randomised trials: systematic review and patient level meta-analysis
Simon J. Adamson et al.
BMJ-BRITISH MEDICAL JOURNAL (2008)
Identification of negative predictors of pain-free response to triptans: Analysis of the eletriptan database
H-C Diener et al.
CEPHALALGIA (2008)
Cessation versus continuation of 6-month migraine preventive therapy with topiramate (PROMPT): a randomised, double-blind, placebo-controlled trial
Hans-Christoph Diener et al.
LANCET NEUROLOGY (2007)
The impact of migraine prevention on daily activities:: a longitudinal and responder analysis from three topiramate placebo-controlled clinical trials
Carl Dahlof et al.
HEALTH AND QUALITY OF LIFE OUTCOMES (2007)
Marketed oral triptans in the acute treatment of migraine:: A systematic review on efficacy and tolerability
Julio Pascual et al.
HEADACHE (2007)
Validation of the Migraine-Specific Quality of Life Questionnaire version 2.1 (MSQ v. 2.1) for patients undergoing prophylactic migraine treatment
Jason C. Cole et al.
QUALITY OF LIFE RESEARCH (2007)
Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study
H-C Diener et al.
CEPHALALGIA (2007)
Sumatriptan/naproxen sodium for migraine: Efficacy, health related quality of life, and satisfaction outcomes
Timothy Smith et al.
HEADACHE (2007)
Patients' preference for migraine preventive therapy
Mario Fernando Prieto Peres et al.
HEADACHE (2007)
Prevention of menstrual attacks of migraine - A double-blind placebo-controlled crossover study
E. A. MacGregor et al.
NEUROLOGY (2006)
Assessing the ability of topiramate to improve the daily activities of patients with migraine
Jan Lewis Brandes et al.
MAYO CLINIC PROCEEDINGS (2006)
Improvement in quality of life and activity limitations in migraine patients after prophylaxis. A prospective longitudinal multicentre study
D D'Amico et al.
CEPHALALGIA (2006)
A meta-analysis of the placebo response in acute migraine and how this response may be influenced by some of the characteristics of clinical trials
A Macedo et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Acetaminophen, aspirin, and caffeine in combination versus ibuprofen for acute migraine: Results from a multicenter, double-blind, randomized, parallel-group, single-dose, placebo-controlled study
J Goldstein et al.
HEADACHE (2006)
Sumatriptan nasal spray in adolescent migraineurs: A randomized, double-blind, placebo-controlled, acute study
P Winner et al.
HEADACHE (2006)
Subcutaneous sumatriptan provides symptomatic relief at any pain intensity or time during the migraine attack
M Linde et al.
CEPHALALGIA (2006)
The impact of migraine on daily activities: effect of topiramate compared with placebo
Stephen D. Silberstein et al.
CURRENT MEDICAL RESEARCH AND OPINION (2006)
Early intervention in migraine with sumatriptan tablets 50 mg versus 100 mg: A pooled analysis of data from six clinical trials
P Winner et al.
CLINICAL THERAPEUTICS (2005)
Symptomatic treatment of migraine in children: A systematic review of medication trials
L Damen et al.
PEDIATRICS (2005)
Effects on productivity and quality of life of rizatriptan for acute migraine:: A workplace study
MJA Láinez et al.
HEADACHE (2005)
Impact of participant and physician intervention preferences on randomized trials - A systematic review
M King et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Placebo effects in oral triptan trials: the scientific and ethical rationale for continued use of placebo controls
E Loder et al.
CEPHALALGIA (2005)
Calcitonin gene-related peptide receptor antagonist BIBN4096BS for the acute treatment of migraine
J Olesen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Naratriptan for the treatment of acute migraine: meta-analysis of randomised controlled trials
DM Ashcroft et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2004)
Defeating migraine pain with triptans: A race against the development of cutaneous allodynia
R Burstein et al.
ANNALS OF NEUROLOGY (2004)
Benefits of treating highly disabled migraine patients with zolmitriptan while pain is mild
J Klapper et al.
CEPHALALGIA (2004)
No effect of eletriptan administration during the aura phase of migraine
J Olesen et al.
EUROPEAN JOURNAL OF NEUROLOGY (2004)
Calibration of an item pool for assessing the burden of headaches:: An application of item response theory to the Headache Impact Test (HIT™)
JB Bjorner et al.
QUALITY OF LIFE RESEARCH (2003)
A study of the feasibility of Internet administration of a computerized health survey:: The headache impact test (HIT™)
MS Bayliss et al.
QUALITY OF LIFE RESEARCH (2003)
Migraine disability assessment (MIDAS) score: Relation to headache frequency, pain intensity, and headache symptoms
WF Stewart et al.
HEADACHE (2003)
Efficacy, safety, and tolerability of oral eletriptan for treatment of acute migraine: A multicenter, double-blind, placebo-controlled study conducted in the united states
F Sheftell et al.
HEADACHE (2003)
Comparative efficacy of eletriptan 40 mg versus sumatriptan 100 mg
NT Mathew et al.
HEADACHE (2003)
A six-item short-form survey for measuring headache impact: The HIT-6 (TM)
M Kosinski et al.
QUALITY OF LIFE RESEARCH (2003)
Sum of Pain Intensity Differences (SPID) in migraine trials. A comment based on four rizatriptan trials
P Tfelt-Hansen et al.
CEPHALALGIA (2002)
Triptans (serotonin, 5-HT1B/1D agonists) in migraine:: detailed results and methods of a meta-analysis of 53 trials
MD Ferrari et al.
CEPHALALGIA (2002)
Meta-analyses involving cross-over trials: methodological issues
DR Elbourne et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2002)
What do patients with migraine want from acute migraine treatment?
RB Lipton et al.
HEADACHE (2002)
New guidelines for the management of migraine in primary care
AJ Dowson et al.
CURRENT MEDICAL RESEARCH AND OPINION (2002)
Oral triptans (serotonin 5-HT1B/1D agonists) in acute migraine treatment:: a meta-analysis of 53 trials
MD Ferrari et al.
LANCET (2001)
Selective seratonin 1F (5-HT1F) receptor agonist LY334370 for acute migraine:: a randomised controlled trial
DJ Goldstein et al.
LANCET (2001)
Familial migraine with and without aura:: clinical characteristics and co-occurrence
M Kallela et al.
EUROPEAN JOURNAL OF NEUROLOGY (2001)
Treatment satisfaction, functional status, and health-related quality of life of migraine patients treated with almotriptan or sumatriptan
SS Colman et al.
CLINICAL THERAPEUTICS (2001)
Development and testing of the Migraine Disability Assessment (MIDAS) Questionnaire to assess headache-related disability
WF Stewart et al.
NEUROLOGY (2001)
Triptans in migraine - A comparative review of pharmacology, pharmacokinetics and efficacy
P Tfelt-Hansen et al.
DRUGS (2000)
The prevalence of migraine in women aged 40-74 years:: a population-based study
P Mattson et al.
CEPHALALGIA (2000)
A randomized, double-blind, placebo-controlled study of sumatriptan nasal spray in the treatment of acute migraine in adolescents
P Winner et al.
PEDIATRICS (2000)
Sumatriptan for the range of headaches in migraine sufferers: Results of the spectrum study
RB Lipton et al.
HEADACHE (2000)
Practice parameter: Evidence-based guidelines for migraine headache (an evidence-based review) - Report of the Quality Standards Subcommittee of the American Academy of Neurology
SD Silberstein
NEUROLOGY (2000)
Migraine, quality of life, and depression - A population-based case-control study
RB Lipton et al.
NEUROLOGY (2000)
Determinants of patient satisfaction with migraine therapy
GM Davies et al.
CEPHALALGIA (2000)
Comparison of rizatriptan 10 mg vs. zolmitriptan 2.5 mg in the acute treatment of migraine
J Pascual et al.
CEPHALALGIA (2000)
Subgroup analysis and other (mis)uses of baseline data in clinical trials
SF Assmann et al.
LANCET (2000)
Validity and reliability of the Migraine-Specific Quality of Life Questionnaire (MSQ version 2.1)
BC Martin et al.
HEADACHE (2000)
Ergotamine in the acute treatment of migraine - A review and European consensus
P Tfelt-Hansen et al.
BRAIN (2000)
Share Paper
